 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 3557-------------------------------------------------- |
|
(Abst.) The wearing-off phenomenon of ocrelizumab in patients w/ |
|
MS |
|
By: agate Date: February 17, 2022, 12:41 am |
|
--------------------------------------------------------- |
|
From PubMed (February 16, 2022)--"The wearing-off phenomenon of |
|
ocrelizumab in patients with multiple sclerosis": |
|
https://pubmed.ncbi.nlm.nih.gov/35158470/ |
|
#Post#: 4592-------------------------------------------------- |
|
(Abst.) Exploring the impact of the wearing-off phenomenon in Pw |
|
MS treated w/Ocrevus |
|
By: agate Date: October 20, 2024, 3:21 pm |
|
--------------------------------------------------------- |
|
|
|
From PubMed (October 20, 2024)--"Exploring the impact of |
|
wearing-off phenomenon in ocrelizumab-treated multiple sclerosis |
|
patients: Insights from a comprehensive study": |
|
https://pubmed.ncbi.nlm.nih.gov/39423725/ |
|
***************************************************** |
